Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial. - Hutchison RM; Fraser K; Yang M; Fox T; Hirschhorn E; Njingti E; Scott D; Bedell BJ; Kistner KM; Cedarbaum JM; Evans KC; Graham D; et al. (Neurology, 2024)